These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Sex differences in the association between AD biomarkers and cognitive decline. Koran MEI; Wagener M; Hohman TJ; Brain Imaging Behav; 2017 Feb; 11(1):205-213. PubMed ID: 26843008 [TBL] [Abstract][Full Text] [Related]
17. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults. Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476 [TBL] [Abstract][Full Text] [Related]
18. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM; J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495 [TBL] [Abstract][Full Text] [Related]
19. A data-driven model of biomarker changes in sporadic Alzheimer's disease. Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC; Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224 [TBL] [Abstract][Full Text] [Related]
20. Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Trojanowski JQ; Shaw LM; Bernstein MA; Aisen PS; Weiner M; Petersen RC; Jack CR; Neurology; 2010 Jul; 75(2):143-51. PubMed ID: 20625167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]